2.17
price up icon0.93%   0.02
after-market Handel nachbörslich: 2.16 -0.010 -0.46%
loading
Schlusskurs vom Vortag:
$2.15
Offen:
$2.1425
24-Stunden-Volumen:
18,552
Relative Volume:
0.03
Marktkapitalisierung:
$2.99M
Einnahmen:
$2.45M
Nettoeinkommen (Verlust:
$-5.47M
KGV:
-0.0367
EPS:
-59.1634
Netto-Cashflow:
$-6.05M
1W Leistung:
+3.83%
1M Leistung:
-10.33%
6M Leistung:
+6.37%
1J Leistung:
-98.31%
1-Tages-Spanne:
Value
$2.12
$2.20
1-Wochen-Bereich:
Value
$2.05
$2.2497
52-Wochen-Spanne:
Value
$0.6273
$134.28

Pmgc Holdings Inc Stock (ELAB) Company Profile

Name
Firmenname
Pmgc Holdings Inc
Name
Telefon
888-445-4886
Name
Adresse
120 NEWPORT CENTER DRIVE, NEWPORT BEACH
Name
Mitarbeiter
3
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
ELAB's Discussions on Twitter

Vergleichen Sie ELAB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ELAB
Pmgc Holdings Inc
2.17 2.92M 2.45M -5.47M -6.05M -59.16
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.232 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.34 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 65.36B 14.09B 4.50B 2.96B 39.28

Pmgc Holdings Inc Aktie (ELAB) Neueste Nachrichten

pulisher
May 30, 2025

Elevai Labs stock plunges to 52-week low of $2.09 amid steep decline By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 29, 2025

Elevai Labs stock plunges to 52-week low of $2.09 amid steep decline - Investing.com Australia

May 29, 2025
pulisher
May 22, 2025

Northstrive Biosciences completes phase I research on muscle-wasting treatment - Investing.com

May 22, 2025
pulisher
May 22, 2025

NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia - GlobeNewswire

May 22, 2025
pulisher
May 16, 2025

Northstrive Biosciences Amends License Agreement with MOA Life - TipRanks

May 16, 2025
pulisher
May 14, 2025

PMGC Holdings Inc. Files Quarterly Report for Q1 2025, Highlights Strategic Growth Initiatives - Nasdaq

May 14, 2025
pulisher
May 14, 2025

PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q - The Manila Times

May 14, 2025
pulisher
May 14, 2025

PMGC Holdings Expands into Hot GLP-1 Market While Pursuing Tech Acquisition: Q1 2025 Details Released - Stock Titan

May 14, 2025
pulisher
May 14, 2025

PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market - ADVFN

May 14, 2025
pulisher
May 14, 2025

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

PMGC Capital Takes 5.09% Stake in Alaunos Therapeutics, Eyes Strategic Changes Including Fintech Expansion - Stock Titan

May 14, 2025
pulisher
May 13, 2025

PMGC Holdings inks employee secondment deal with Northstrive By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

PMGC Holdings inks employee secondment deal with Northstrive - Investing.com

May 13, 2025
pulisher
May 13, 2025

Northstrive Biosciences Signs Binding Term Sheet with - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

Northstrive Biosciences Signs Binding Term Sheet with Modulant Biosciences for Exclusive Global Animal Health Licensing of EL-22 - Stock Titan

May 13, 2025
pulisher
May 05, 2025

PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance - ADVFN

May 05, 2025
pulisher
May 02, 2025

PMGC Holdings Inc: Navigating Market Fluctuations with a 2.72M Market Cap - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

ELAB’s price-to-free cash flow ratio: How it affects investment decisions - uspostnews.com

May 02, 2025
pulisher
May 02, 2025

PMGC Holdings (ELAB) Continues Uptrend During Pre-Hours On Positive Sentiment - Stocks Telegraph

May 02, 2025
pulisher
May 01, 2025

ELAB Stock Price and Chart — NASDAQ:ELAB - TradingView

May 01, 2025
pulisher
Apr 29, 2025

RESENDNorthstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health - GlobeNewswire

Apr 29, 2025
pulisher
Apr 29, 2025

Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health - The Manila Times

Apr 29, 2025
pulisher
Apr 29, 2025

Northstrive Biosciences Strengthens IP Portfolio with New - GlobeNewswire

Apr 29, 2025
pulisher
Apr 29, 2025

Northstrive Expands Patent Portfolio: New GLP-1 Combo Treatment Could Prevent Muscle Loss in Obesity - Stock Titan

Apr 29, 2025
pulisher
Apr 29, 2025

Northstrive Biosciences files patents for obesity treatments By Investing.com - Investing.com India

Apr 29, 2025
pulisher
Apr 28, 2025

Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial - The Manila Times

Apr 28, 2025
pulisher
Apr 28, 2025

Northstrive Biosciences Co-Founder Featured on Bear Bull - GlobeNewswire

Apr 28, 2025
pulisher
Apr 25, 2025

Elevai Labs stock plunges to 52-week low of $2.22 amid steep decline - Investing.com India

Apr 25, 2025
pulisher
Apr 25, 2025

Ratios Reveal: Breaking Down PMGC Holdings Inc (ELAB)’s Financial Health - DWinneX

Apr 25, 2025
pulisher
Apr 24, 2025

ELAB’s Stock Journey: What Investors Need to Know About PMGC Holdings Inc’s Performance - investchronicle.com

Apr 24, 2025
pulisher
Apr 24, 2025

Elevai Labs stock plunges to 52-week low of $2.22 amid steep decline By Investing.com - Investing.com South Africa

Apr 24, 2025
pulisher
Apr 24, 2025

What is ELAB’s price-to-sales ratio telling us about the company’s value? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment - GlobeNewswire

Apr 24, 2025
pulisher
Apr 19, 2025

Key deals this week: Vista Energy, PMGC Holdings, Colliers, John Wood and more - Seeking Alpha

Apr 19, 2025
pulisher
Apr 16, 2025

PMGC Signs Letter of Intent to Purchase Custom IT Packaging Firm; Shares Fall - marketscreener.com

Apr 16, 2025
pulisher
Apr 16, 2025

ELAB stock touches 52-week low at $2.51 amid steep annual decline - Investing.com

Apr 16, 2025
pulisher
Apr 16, 2025

PMGC signs letter of intent to acquire U.S.-based custom IT packaging company - TipRanks

Apr 16, 2025
pulisher
Apr 16, 2025

Pmgc Holdings Signs Letter Of Intent To Acquire Profitable U.S.-Based Custom It Packaging Company - MarketScreener

Apr 16, 2025
pulisher
Apr 16, 2025

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company - GlobeNewswire

Apr 16, 2025
pulisher
Apr 16, 2025

Strategic Acquisition: PMGC Eyes IT Packaging Leader Serving Major Data Centers - Stock Titan

Apr 16, 2025
pulisher
Apr 12, 2025

PMGC’s Northstrive Biosciences signs partnership with Yuva Biosciences - TipRanks

Apr 12, 2025
pulisher
Apr 10, 2025

PMGC Stock Surges After Subsidiary Inks Deal With Yuva Biosciences To Develop AI Led Therapies - Benzinga

Apr 10, 2025
pulisher
Apr 10, 2025

ELAB Stock Soars: Buy Now Or Wait? - timothysykes.com

Apr 10, 2025
pulisher
Apr 10, 2025

Northstrive Biosciences Signs Partnership with Yuva - GlobeNewswire

Apr 10, 2025
pulisher
Apr 08, 2025

Elevai Labs stock plunges to 52-week low of $3.86 amid steep decline - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

Elevai Labs stock plunges to 52-week low of $3.86 amid steep decline By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Mar 30, 2025

PMGC Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - MarketScreener

Mar 30, 2025
pulisher
Mar 28, 2025

PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K - The Manila Times

Mar 28, 2025
pulisher
Mar 28, 2025

PMGC Holdings Targets Multiple Acquisitions to Accelerate Growth Strategy - Stock Titan

Mar 28, 2025

Finanzdaten der Pmgc Holdings Inc-Aktie (ELAB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.15
price up icon 0.00%
$585.93
price up icon 0.92%
$300.83
price down icon 2.33%
$38.11
price up icon 4.30%
$4.73
price down icon 1.69%
$493.22
price up icon 2.10%
Kapitalisierung:     |  Volumen (24h):